OBSTETRICS AND GYNECOLOGY
News

Current Impact Factor (2023): 2,4

GebFra in eRef App

Nutzen Sie als GebFra-Abonnent Ihr Abo in der eRef App:

  • Sie können die GebFra bequem offline lesen – laden Sie sich einfach die Ausgaben auf Ihr Smartphone/Tablet.
  • Die eRef App ist eine native App für Android und iOS – sie kann mit Smartphones/Tablets wie z. B. dem iPhone und dem iPad benutzt werden.
  • Ab sofort steht Ihnen die ausgefeilte eRef-Suche zur Verfügung.
  • Sämtliche Thieme Zeitschriften, die Sie abonniert haben, bündelt die eRef App für Sie an einer Stelle.

So geht's

Hier erfahren Sie, wie Sie Ihr GebFra-Abo in der eRef App freischalten:

www.thieme.de/eref-app

Ihr Veranstaltungstermin

Auf Ihre Veranstaltung zum Thema Gynäkologie und Geburtshilfe können Sie tagesaktuell online über unsere Community für Geburtshilfe und Frauenheilkunde hinweisen. Einfach auf unten stehenden Link klicken, Formular ausfüllen, abschicken, fertig!
 

Statements


Recommendations for Care and Support of Female Rape Victims

Diagnosis and Therapy of Iron Deficiency Anemia During Pregnancy: Recommendation of the Austrian Society for Gynecology and Obstetrics (OEGGG)

Recommendations of the AGG (Section Maternal Disease) for Myasthenia Gravis in Pregnancy

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

AGO Algorithms for the Treatment of Breast Cancer: Update 2021

Recommendations of the AGG (Task Force for Obstetrics, Section Maternal Diseases) on the Management of Maternal Hepatitis B, C and D Infection in Pregnancy

Statement of the AGO and AG-CPC on the Aftercare/Follow-up for Surgical Procedures of the Lower Genital Tract after the Introduction of a New Cancer Screening Guideline

Adjuvant Radiotherapy and/or Chemotherapy for Endometrial Cancer, Status as at 2019

Position Paper of the Task Force for Obstetrics and Prenatal Medicine (AGG – Section Preterm Birth) on the Placement, Removal and Surveillance of the Arabin Cervical Pessary in Patients at Risk for Spontaneous Preterm Birth

MR-Guided Focused Ultrasound[*] in Fibroid Treatment – Results of the 4th Radiological-Gynecological Expert Meeting

Uterine Artery Embolization (UAE) for Fibroid Treatment – Results of the 7th Radiological Gynecological Expert Meeting

Response to: Dittrich et al.: Non-Embryo-Destructive Extraction of Pluripotent Embryonic Stem Cells – Overlooked Legal Prohibitions, Professional Legal Consequences and Inconsistencies in Patent Law

Editorʼs Comment on the Review of the German IVF Register and the Subsequent Discussion

Comment by the Board of the German IVF Register on the Article "The German IVF Register as an Instrument to Document Assisted Reproductive Technologies" by S. Kadi and U. Wiesing

Response to the Comment by the Board of the German IVF Register

Comment on the New DGGG AWMF S3-Guideline on Hysterectomy, or a Plea for LAVH as the Gold Standard for Total Hysterectomy Procedures

Response to the "Comment on the New DGGG AWMF S3-Guideline on Hysterectomy, or a Plea for LAVH as the Gold Standard for Total Hysterectomy Procedures" by Prof. Rudy Leon De Wilde

New Screening Proposals: the Federal Joint Commission Defines the Parameters for Cervical Cancer Screening from 2018

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer

Precancerous Lesions of the Cervix, Vulva and Vagina According to the 2014 WHO Classification of Tumors of the Female Genital Tract

Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Magnetic Resonance Guided Focused Ultrasound[#] for Fibroid Treatment – Results of the Second Radiological Gynecological Expert Meeting

Uterine Artery Embolization (UAE) for Fibroid Treatment – Results of the 5th Radiological Gynecological Expert Meeting

Should Fallopian Tubes Be Removed During Hysterectomy Procedures? – A Statement by AGO Ovar

New WHO Classification of Endometrial Hyperplasias

Is the Outcome Indicator "3rd/4th Degree Perineal Tear in Spontaneous Singleton Births" a Reliable Quality Parameter in Obstetrics?